See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case 1: Left Main Disease with Syntax Score >32 PCI vs. CABG

Presenter: Takeshi Kimura

October 22, 2012

Presentation TCT 2012

The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes

Presenter: Philip Green

October 22, 2012

Presentation TCT 2012

Stent Thrombosis Meta-analysis

Presenter: Tullio Palmerini

October 22, 2012

Presentation TCT 2012

Aortic Stenosis Diagnostic and Therapeutic Clinical Pearls: A Selective View from the Guidelines (and Beyond): What Is KNOWN!

Presenter: Blase Carabello

October 22, 2012

Presentation TCT 2012

Step 3: Intellectual Property

Presenter: Casey McGlynn

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

Presentation TCT 2012

Structural Heart Disease Intervention: Perspectives from the Russian Federation Database

Presenter: Bagrat Alekyan

October 22, 2012

Presentation TCT 2012

When Do I Prefer Transsubclavian/Axillary Alternative Access for TAVR?

Presenter: Jean-Claude Laborde

October 22, 2012

Presentation TCT 2012

European Perspectives

Presenter: Christian Hengstenberg

October 22, 2012

Presentation TCT 2012

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Presenter: Alessandro Bortone

October 22, 2012

Advertisement

Slides

Case 1: Left Main Disease with Syntax Score >32 PCI vs. CABG

The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes

Stent Thrombosis Meta-analysis

Aortic Stenosis Diagnostic and Therapeutic Clinical Pearls: A Selective View from the Guidelines (and Beyond): What Is KNOWN!

Step 3: Intellectual Property

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Structural Heart Disease Intervention: Perspectives from the Russian Federation Database

When Do I Prefer Transsubclavian/Axillary Alternative Access for TAVR?

European Perspectives

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content